Company intelligence / Profile preview

Archetype Therapeutics

Ownership
Private
Employees
~6
Development stage
Preclinical
01

Overview

Archetype Therapeutics uses AI and patient clinicogenomic data to virtually screen billions of drug-like molecules daily, predicting clinical outcomes for various diseases.

Therapeutic areas
OncologyPulmonology
Modalities
Small molecules
Industry
Biotech
02

Partnerships

Partnerships across the healthcare and life sciences ecosystem

Beyond the preview

Go deeper on Archetype Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Archetype Therapeutics.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call